TransMedics Group WKN: A2PH5P ISIN: US89377M1099 Kürzel: TMDX Branche: Gesundheit, Medizinische, Instrumente, Zubehör
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
![Smartbroker entdecken]()
![Jetzt Smartbroker]()
![Smartbrokerplus]()
Summer.76,
TransMedics Group
Hauptdiskussion, 16. Aug 22:28
https://www.prnewswire.com/news-releases/transmedics-completes-acquisition-of-summit-aviation-301902891.html
Summer.76,
TransMedics Group
Hauptdiskussion, 8. Aug 17:47
TransMedics: Aircraft Additions Bring Immense Gross-Value Add, Reiterate Buy
https://seekingalpha.com/article/4625251-transmedics-aircraft-additions-immense-gross-value-add
Summary
• TransMedics Group, Inc. posted exceptional Q2 results with a 156% YoY increase in revenues, reaching the highest second-quarter turnover in the company's history.
• The company aims to have 100% availability over the U.S. continent by mid-next year, with plans to acquire 10-15 aircrafts for its air logistics operations.
• Net-net, reiterate buy, revising the price objective to $150/share.
...
T
Tommy87,
TransMedics Group
Hauptdiskussion, 8. Aug 9:21
Ouch, bin wieder drin
Summer.76,
TransMedics Group
Hauptdiskussion, 3. Aug 22:07
https://www.prnewswire.com/news-releases/transmedics-reports-second-quarter-2023-financial-results-301893091.html
Summer.76,
TransMedics Group
Hauptdiskussion, 3. Aug 7:13
https://www.prnewswire.com/news-releases/transmedics-acquires-warm-perfusion-evoss-and-cold-perfusion-lifecradle-technologies-from-bridge-to-life-301892032.html
Summer.76,
TransMedics Group
Hauptdiskussion, 1. Aug 20:19
https://www.prnewswire.com/news-releases/transmedics-signs-definitive-agreement-to-acquire-summit-aviation-to-expand-transmedics-aviation-capabilities-for-organ-transplantation-301890528.html
Summer.76,
TransMedics Group
Hauptdiskussion, 01.05.2023 22:32
TransMedics Reports First Quarter 2023 Financial Results
https://finance.yahoo.com/news/transmedics-reports-first-quarter-2023-200500397.html
Summer.76,
TransMedics Group
Hauptdiskussion, 23.02.2023 16:33
🍀
Summer.76,
TransMedics Group
Hauptdiskussion, 22.02.2023 22:52
TransMedics Group Q4 EPS $(0.21) Beats $(0.30) Estimate, Sales $31.38M Beat $24.45M Estimate
https://www.benzinga.com/news/earnings/23/02/31017364/transmedics-group-q4-eps-0-21-beats-0-30-estimate-sales-31-38m-beat-24-45m-estimate
TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.30) by 30 percent. This is a 54.35 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $31.38 million which beat the analyst consensus estimate of $24.45 million by 28.32 percent. This is a 224.52 percent increase over sales of $9.67 million the same period last year.
Summer.76,
TransMedics Group
Hauptdiskussion, 22.02.2023 22:44
https://seekingalpha.com/news/3939484-transmedics-q4-results-beat-estimates-co-sees-fy-2023-revenue-above-consensus
TransMedics Q4 results beat estimates, co sees FY 2023 revenue above consensus
• TransMedics Group press release (NASDAQ:TMDX): Q4 GAAP EPS of -$0.21 beats by $0.11.
• Revenue of $31.4M (+223.7% Y/Y) beats by $7.8M.
• Expects total revenue for full-year 2023 to be in the range of $138 million to $145 million. The consensus estimate is $134.66M.
Summer.76,
TransMedics Group
Hauptdiskussion, 22.02.2023 22:14
TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
https://www.prnewswire.com/news-releases/transmedics-reports-fourth-quarter-and-full-year-2022-financial-results-301753645.html
Summer.76,
TransMedics Group
Hauptdiskussion, 02.02.2023 22:10
https://www.prnewswire.com/news-releases/transmedics-appoints-nick-corcoran-as-senior-vice-president-of-supply-chain-and-operations-301737904.html
Summer.76,
TransMedics Group
Hauptdiskussion, 07.11.2022 22:07
https://www.prnewswire.com/news-releases/transmedics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301670734.html
Summer.76,
TransMedics Group
Hauptdiskussion, 03.11.2022 21:51
🍀
Summer.76,
TransMedics Group
Hauptdiskussion, 03.11.2022 21:44
TransMedics Group GAAP EPS of -$0.25 beats by $0.15, revenue of $25.7M beats by $6.82M
https://seekingalpha.com/news/3901375-transmedics-group-gaap-eps-of-0_25-beats-0_15-revenue-of-25_7m-beats-6_82m
• TransMedics Group press release (NASDAQ:TMDX): Q3 GAAP EPS of -$0.25 beats by $0.15.
• Revenue of $25.7M (+378.6% Y/Y) beats by $6.82M.
• 2022 Financial Outlook:
• TransMedics is updating full year 2022 revenue to be in the range of $80 million to $85 million vs $75.70M consensus, excluding the $1.4 million favorable change in estimate for contra revenue, which represents 164% to 181% growth compared to the company's prior year revenue. TransMedics' prior 2022 net revenue guidance was $67 million to $75 million.
|
|
Themen zum Wert | ||
|---|---|---|---|
| 1 | TransMedics Group Hauptdiskussion |
Kursdetails
| Geld (bid) | 51,66 (1.100) |
|---|---|
| Brief (ask/offer) | 51,67 (200) |
| Spread | 0,02 |
| Geh. Stück | 925 Tsd. |
| Eröffnung | 52,52 |
| Vortag | 52,78 |
| Tageshoch | 54,99 |
| Tagestief | 50,83 |
| 52W Hoch | 99,63 |
| 52W Tief | 38,86 |
Tagesvolumen
| in USD gehandelt | 925 Tsd. Stk |
|---|---|
| in EUR gehandelt | 14 Stk |
| Gesamt | 925 Tsd. Stk |
Anzeige
![Smartbroker entdecken]()
![Jetzt Smartbroker]()
![Smartbrokerplus]()
Anzeige
IG EUROPE
- Goldpreis rutscht unter 1.850 Dollar – US-Arbeitsmarktdaten werfen Schatten voraus
- DAX 40 Wochenausblick: „Shutdown“ in den USA abgewendet – Anleger hoffen auf Trendwende
- EUR/USD: EU-Inflation verliert an Schwung – PCE-Daten ohne größere Überraschungen
- Bitcoin Kurs nach BlackRock-Verzögerung dennoch über 27.000 Dollar – Ether-Futures im Blick
Meldungen
- Kursrutsch geht weiter
- Novartis vollzieht mit Sandoz-Spin-Off eigenen Wandel - Ziele bestätigt
- Heinz Strunk und der Ballermann
- Rund ein Drittel der Deutschen sorgt weniger fürs Alter vor
- VARTA AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Geld/Brief Kurse
Neu laden| Börse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
|---|---|---|---|---|---|---|---|
| NYS | 51,53 | 200 Stk | 51,84 | 100 Stk | 1696377600 02:00 | 51,67 USD | |
| AMEX | 40,72 | 100 Stk | 63,61 | 100 Stk | 1696377600 02:00 | 52,16 USD | |
| Frankfurt | 48,94 | 150 Stk | 49,66 | 150 Stk | 1696317301 3. Oct | 49,98 EUR | |
| Tradegate | 48,91 | 123 Stk | 49,65 | 121 Stk | 1696364818 3. Oct | 14 Stk | 49,54 EUR |
| Berlin | 48,34 | 500 Stk | 50,30 | 400 Stk | 1696362728 3. Oct | 49,44 EUR | |
| München | 49,58 | 150 Stk | 49,90 | 200 Stk | 1696312807 3. Oct | 50,10 EUR | |
| Stuttgart | 48,98 | 123 Stk | 49,60 | 200 Stk | 1696363172 3. Oct | 49,10 EUR | |
| Nasdaq | 51,66 | 1.100 Stk | 51,67 | 200 Stk | 1696377600 02:00 | 925 Tsd. Stk | 51,67 USD | ges. 925.295 Stk |
Realtime / Verzögert
Börsennotierung
| Marktkapitalisierung in EUR |
|---|
| 1,6 Mrd. |
| Anzahl der Aktien |
| 32,5 Mio. |
Grundlegende Daten zur TransMedics Group Aktie
| Finanzdaten | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|---|
| KUV | 17,13 | 21,17 | 17,58 | 21,14 | - | - | - |
| Ergebnis je Aktie (bereinigt) | - | - | - | - | - | - | - |
| Cashflow | -32,3 Mio. | -30,3 Mio. | -28,9 Mio. | -45,8 Mio. | - | - | - |
| Eigenkapitalquote | 51,90 % | 68,34 % | 50,30 % | 67,61 % | - | - | - |
| Verschuldungsgrad | 92,68 | 46,33 | 98,80 | 47,91 | - | - | - |
| Eigenkapitalrendite | - | - | - | - | - | - | - |
| Gesamtkapitalrendite | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT | -29,6 Mio. | -26,4 Mio. | -39,4 Mio. | -31,4 Mio. | - | - | - |
| Fundamentaldaten | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e |
| KCV | - | - | - | - | - | - | - |
| Dividendenrendite | - | - | - | - | - | - | - |
| Kurs-Gewinn-Verhältnis (KGV) | - | - | - | - | - | - | - |
| Dividende je Aktie | - | - | - | - | - | - | - |
| Bilanzdaten | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e |
| Netto-Provisionsüberschuss | - | - | - | - | - | - | - |
| Umsatzerlöse | 23,6 Mio. | 25,6 Mio. | 30,3 Mio. | 93,5 Mio. | - | - | - |
| Ergebnis vor Steuern | -33,5 Mio. | -28,7 Mio. | -44,2 Mio. | -36,2 Mio. | - | - | - |
| Steuern | 40.000 | 32.000 | 36.000 | 66.000 | - | - | - |
| Ausschüttungssumme | - | 357 Tsd. | - | - | - | - | - |
| Nettoverzinsung | - | - | - | - | - | - | - |
| Zinsertrag | - | - | - | - | - | - | - |
| Gesamtertrag | - | - | - | - | - | - | - |